Abstract
Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion. Intratumoral hypoxia and genetic alterations can lead to HIF-1α overexpression, which has been associated with increased patient mortality in several cancer types. In preclinical studies, inhibition of HIF-1 activity has marked effects on tumour growth. Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.
Original language | English (US) |
---|---|
Pages (from-to) | 721-732 |
Number of pages | 12 |
Journal | Nature Reviews Cancer |
Volume | 3 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2003 |
ASJC Scopus subject areas
- Oncology
- Cancer Research